Two new broker notes out last week on this one -

Collins Stewart gives a target valuation for the combined entity of 26 million or 156p per share

Edison Investments embedded valuation is 31m - Indicating a 100% gain in share price from current levels. They suggest that using the current embedded valuation model, the current value of Angles six non-exited ventures is only 5.5m - suggesting Angle to be SIGNIFICANTLY UNDERVALUED

Have a look

Link copied :- Biotech minnow Angle triumphs with cancer blood testing kit

More good news....could be a real winner this year, this company....

Had a few last week.

Looks promising.

£1 by xmas :-)